Imunon (IMNN) Earnings Date & Reports

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

IMNN is expected to report earnings to rise 17.86% to -99 cents per share on August 06

Q2'26

Est.

$-0.99

Q1'26

Missed

by $0.69

Q4'25

Missed

by $1.22

Q3'25

Missed

by $0.95

Q2'25

Missed

by $1.83

The last earnings report on May 12 showed earnings per share of -83 cents, missing the estimate of -14 cents. With 34.37K shares outstanding, the current market capitalization sits at 7.65M.

View a ticker or compare two or three

Compare

IMNN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for IMNN